MedTrace Logo

Expression of Optic Atrophy Type 1 (OPA1) Protein in Lung Adenocarcinoma

NCT01249053 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2010-11-29

No results posted yet for this study

Summary

Optic atrophy type 1(OPA1) is a nuclear dynamin-related GTPase, targeted to the inner mitochondrial membrane, which plays a role in mitochondrial fusion. Mitochondria fusion is associated with process of apoptosis. . OPA1 plays an important role in the mitochondrial bioenergetics and mitochondrial networks. The changes in mitochondrial shape and mitochondrial bioenergetics may be cause of the disease. In this study, we investigate the expression of OPA1 in lung adenocarcinoma (LADC) cells and tissue.

Conditions

Sponsors & Collaborators

  • China Medical University Hospital

    lead OTHER

Eligibility

Min Age
25 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01249053 on ClinicalTrials.gov